BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$15.23
-0.02 (-0.13%)
▼
5d:
-4.63%
30d:
-0.39%
90d:
-8.03%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
9d
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 13.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 13.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$14.61
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $15.23, which is considered fair relative to its 30-day fair value range of $14.58 to $15.96. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.5) compared to its historical average (48.7). Remarkably, the market is currently pricing in an annual earnings decline of 13.5% over the next few years. This pessimistic expectation contrasts with the company's recent 200% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BWAY is in a uptrend. Immediate support is located at $14.14, while resistance sits at $17.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.67 (+16.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BWAY is in a uptrend. Immediate support is located at $14.14, while resistance sits at $17.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.67 (+16.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$14.58 -
$15.96
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($17.67)
Trading Range Analysis
30-Day Trading Range
$14.58 -
$15.96
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$14.14
Resistance Level
$17.29
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.51
Wall Street Target
$17.67
(+16.0%)
Revenue Growth (YoY)
34.6%
Earnings Growth (YoY)
200.0%
Profit Margin
15.6%
Valuation Discount vs History
-13.5% cheaper
PE vs Historical
31.5 vs 48.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.5%
(market-implied from PE analysis)
1-Year Target
$13.71
(-10%)
2-Year Target
$12.34
(-19%)
3-Year Target
$11.10
(-27%)
3-Yr Target (if PE normalizes)
(PE: 32→49)
$17.16
(+13%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.5, Growth: 57.6%)
$51.40
(+238%)
Base:
(SPY PE: 20.7, Growth: 57.6%)
$33.81
(+122%)
Bear:
(PE: 17.6, Growth: 57.6%)
$28.74
(+89%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (32x PE) as earnings recover.
Forward PE: 33.67 | Forward EPS (Implied): $0.45
Bull Case
$18.39
(+21%)
Analyst growth 15.0%, PE expands to 35.4
Base Case
$15.23
(0%)
Market implied 0.0%, PE stable at 33.7
Bear Case
$11.65
(-24%)
Severe decline -15.0%, PE contracts to 30.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.5 to 48.7
Stabilization Target:
$23.54
(+54.5%)
PE Expansion Potential:
+54.5%
Share & Embed Analysis
Last updated: August 02, 2026 2:59 PM ET
Data refreshes hourly during market hours. Next update: 3:59 PM
Data refreshes hourly during market hours. Next update: 3:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
